Andrey Ugolkov

1.9k total citations
44 papers, 1.5k citations indexed

About

Andrey Ugolkov is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Andrey Ugolkov has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 18 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Andrey Ugolkov's work include Wnt/β-catenin signaling in development and cancer (12 papers), Cancer-related gene regulation (9 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Andrey Ugolkov is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (12 papers), Cancer-related gene regulation (9 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Andrey Ugolkov collaborates with scholars based in United States, Japan and Spain. Andrey Ugolkov's co-authors include Andrew P. Mazar, Thomas V. O’Halloran, Vladimir Bilim, Yoshihiko Tomita, Daniel D. Billadeau, Francis J. Giles, Kaori Yuuki, Vincent L. Cryns, Alan P. Kozikowski and Teiichi Motoyama and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Andrey Ugolkov

43 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrey Ugolkov United States 24 899 453 325 188 160 44 1.5k
Manuela Porru Italy 27 1.4k 1.5× 693 1.5× 303 0.9× 141 0.8× 146 0.9× 48 2.1k
Antonella Zannetti Italy 27 1.1k 1.2× 669 1.5× 426 1.3× 177 0.9× 145 0.9× 66 2.0k
Patrizia Perri Italy 24 817 0.9× 327 0.7× 376 1.2× 137 0.7× 168 1.1× 57 1.6k
Bedrich L. Eckhardt United States 19 741 0.8× 626 1.4× 317 1.0× 156 0.8× 89 0.6× 26 1.5k
Sara Granja Portugal 25 839 0.9× 297 0.7× 666 2.0× 153 0.8× 108 0.7× 40 1.5k
Yoshikatsu Koga Japan 24 870 1.0× 576 1.3× 464 1.4× 167 0.9× 409 2.6× 69 1.7k
Yasuhito Onodera Japan 25 1.3k 1.5× 542 1.2× 447 1.4× 156 0.8× 130 0.8× 46 2.1k
Marina Bagnoli Italy 25 1.2k 1.3× 631 1.4× 623 1.9× 172 0.9× 118 0.7× 50 2.1k
Jacqueline Banyard United States 14 593 0.7× 309 0.7× 266 0.8× 124 0.7× 203 1.3× 18 1.1k
Nathaniel R. Campbell United States 20 1.2k 1.3× 510 1.1× 631 1.9× 129 0.7× 86 0.5× 24 1.7k

Countries citing papers authored by Andrey Ugolkov

Since Specialization
Citations

This map shows the geographic impact of Andrey Ugolkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrey Ugolkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrey Ugolkov more than expected).

Fields of papers citing papers by Andrey Ugolkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrey Ugolkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrey Ugolkov. The network helps show where Andrey Ugolkov may publish in the future.

Co-authorship network of co-authors of Andrey Ugolkov

This figure shows the co-authorship network connecting the top 25 collaborators of Andrey Ugolkov. A scholar is included among the top collaborators of Andrey Ugolkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrey Ugolkov. Andrey Ugolkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahalingam, Devalingam, Anwaar Saeed, Steven Powell, et al.. (2025). Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer. ESMO Open. 10(6). 105122–105122. 2 indexed citations
2.
3.
Weiskittel, Taylor M., Benedito A. Carneiro, Hu Li, et al.. (2024). Identification of immune biomarkers in treatment-naive patients with metastatic pancreatic cancer treated with the GSK-3 inhibitor elraglusib (9-ING-41) in combination with gemcitabine/nab-paclitaxel in the 1801 phase 2 study.. Journal of Clinical Oncology. 42(16_suppl). e16331–e16331. 1 indexed citations
4.
Ugolkov, Andrey, et al.. (2021). Abstract 385: Identification of NF-kappaB phospho-p50 as a predictive biomarker for IRAK4 inhibitor CA-4948 in patients with non-Hodgkin's lymphoma. Cancer Research. 81(13_Supplement). 385–385. 1 indexed citations
5.
Bilim, Vladimir, Masayuki Tasaki, Andrew P. Mazar, et al.. (2019). 9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer. Scientific Reports. 9(1). 19977–19977. 43 indexed citations
6.
Johnson, Steven, Andrey Ugolkov, Chad R. Haney, et al.. (2018). Whole-body Imaging of Cell Death Provides a Systemic, Minimally Invasive, Dynamic, and Near-real Time Indicator for Chemotherapeutic Drug Toxicity. Clinical Cancer Research. 25(4). 1331–1342. 13 indexed citations
7.
Romero‐Calvo, Isabel, Christopher R. Weber, Mohana Ray, et al.. (2018). Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma Tumors. Molecular Cancer Research. 17(1). 70–83. 86 indexed citations
8.
Ugolkov, Andrey, Gennadiy Bondarenko, Oleksii Dubrovskyi, et al.. (2018). 9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma. Anti-Cancer Drugs. 29(8). 717–724. 27 indexed citations
9.
Almassalha, Luay M., Greta M. Bauer, Lusik Cherkezyan, et al.. (2017). Macrogenomic engineering via modulation of the scaling of chromatin packing density. Nature Biomedical Engineering. 1(11). 902–913. 32 indexed citations
10.
Matsangou, Maria, Andrey Ugolkov, Timothy Taxter, et al.. (2017). Abstract 1127: Aberrant nuclear expression of GSK-3beta in human head and neck carcinoma. Cancer Research. 77(13_Supplement). 1127–1127. 1 indexed citations
11.
Ugolkov, Andrey, Wenan Qiang, Gennadiy Bondarenko, et al.. (2017). Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models. Translational Oncology. 10(4). 669–678. 31 indexed citations
12.
Jiménez, Benilde, Elena Vinokour, Oleksii Dubrovskyi, et al.. (2016). Melanoma Cells Block PEDF Production in Fibroblasts to Induce the Tumor-Promoting Phenotype of Cancer-Associated Fibroblasts. Cancer Research. 76(8). 2265–2276. 38 indexed citations
13.
Ugolkov, Andrey, Irina N. Gaisina, Jin‐San Zhang, et al.. (2016). GSK-3 inhibition overcomes chemoresistance in human breast cancer. Cancer Letters. 380(2). 384–392. 63 indexed citations
14.
Bondarenko, Gennadiy, Andrey Ugolkov, Stephen Rohan, et al.. (2015). Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors. Neoplasia. 17(9). 735–741. 65 indexed citations
15.
Gaisina, Irina N., W. TUECKMANTEL, Andrey Ugolkov, et al.. (2015). Identification of HDAC6‐Selective Inhibitors of Low Cancer Cell Cytotoxicity. ChemMedChem. 11(1). 81–92. 30 indexed citations
16.
Dam, Duncan Hieu M., Kayla S. B. Culver, Irawati Kandela, et al.. (2014). Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars. Nanomedicine Nanotechnology Biology and Medicine. 11(3). 671–679. 73 indexed citations
17.
18.
Malin, Dmitry, Elena Strekalova, Vladimír Petrovič, et al.. (2013). αB-Crystallin: A Novel Regulator of Breast Cancer Metastasis to the Brain. Clinical Cancer Research. 20(1). 56–67. 81 indexed citations
19.
Yemelyanov, Alexander, Pankaj Bhalla, Andrey Ugolkov, Ximing J. Yang, & Irina Budunova. (2012). Abstract 3929: Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: A novel therapeutic modality. Cancer Research. 72(8_Supplement). 3929–3929. 3 indexed citations
20.
Naito, Sei, Vladimir Bilim, Kaori Yuuki, et al.. (2010). Glycogen Synthase Kinase-3β: A Prognostic Marker and a Potential Therapeutic Target in Human Bladder Cancer. Clinical Cancer Research. 16(21). 5124–5132. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuela Porru Breakdown of academic impact, for papers by Antonella Zannetti Breakdown of academic impact, for papers by Patrizia Perri Breakdown of academic impact, for papers by Bedrich L. Eckhardt Breakdown of academic impact, for papers by Sara Granja Breakdown of academic impact, for papers by Yoshikatsu Koga Breakdown of academic impact, for papers by Yasuhito Onodera Breakdown of academic impact, for papers by Marina Bagnoli Breakdown of academic impact, for papers by Jacqueline Banyard Breakdown of academic impact, for papers by Nathaniel R. Campbell
Rankless by CCL
2026